Log in to save to my catalogue

Review of the clinical applications and technological advances of circulating tumor DNA in cancer mo...

Review of the clinical applications and technological advances of circulating tumor DNA in cancer mo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b4e4638bad354831837152328cd8ebde

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring

About this item

Full title

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Therapeutics and clinical risk management, 2017-01, Vol.13, p.1363-1374

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Circulating cell-free DNA (cfDNA) released by tumor cells, termed ctDNA, closely reflects the heterogeneity of primary cancers and their metastases. As a noninvasive, real-time monitoring biomarker, ctDNA is a promising tool for detecting driver gene mutations, assessing tumor burden and acquired resistance, and early diagnosis. However, isolation...

Alternative Titles

Full title

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b4e4638bad354831837152328cd8ebde

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b4e4638bad354831837152328cd8ebde

Other Identifiers

ISSN

1178-203X,1176-6336

E-ISSN

1178-203X

DOI

10.2147/TCRM.S141991

How to access this item